Medication Errors: FDA Renews Focus On Drug Packaging As Part Of Prevention Campaign
This article was originally published in The Pink Sheet Daily
Executive Summary
June workshop is first step in development of a guidance addressing what drug developers can do to reduce mistakes.
You may also be interested in...
Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging
Reducing the amount of unnecessary information on drug labels is one of several key ways to stop dangerous medication errors, a panel that is helping FDA develop guidance on the subject agreed
Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging
Reducing the amount of unnecessary information on drug labels is one of several key ways to stop dangerous medication errors, a panel that is helping FDA develop guidance on the subject agreed
Transcept Aims To Refile Intermezzo Insomnia NDA In Late Q4 With Highway Driving Data
FDA approved a resubmission plan that responds to concerns about inadvertent re-dosing and next-day driving impairment raised in an October "complete response" letter.